HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Gil Bolotin Emile Bacha Valluvan Jeevanandam Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Bolotin, G. Articles by Jeevanandam, V. Search for Related Content PubMed PubMed Citation Articles by Bolotin, G. Articles by Jeevanandam, V.

Glutamine Improves Myocardial Function Following Ischemia-Reperfusion Injury

Division of Cardiothoracic, Surgery Pritzker School of Medicine, University of Chicagom, USA

For reprint information contact: Gil Bolotin, MD, Tel: 31 43 387 7070, Fax: 31 43 387 5075, Email: g_bolotin{at}rambam.health.gov.il, Department of Cardiothoracic Surgery, Academic Hospital, Maastricht, P. Debyelaan 25, Postbus 5800, 6202 AZ, Maastricht, Netherlands.

Myocardial ischemia-reperfusion injury is common during cardiac procedures. Glutamine may protect the myocardium by preserving metabolic substrates. Glutamine (0.52 g·kg^–1) or Ringer’s lactate solution (control group) was administered intraperitoneally to 63 Sprague-Dawley rats at 4 or 18 hours prior to experimental ischemia and reperfusion. The hearts were excised and perfused on an isolated working heart model, exposed to global ischemia for 15 min and reperfusion for 1 hour. Left atrial pressure, mean aortic pressure, cardiac flow, coronary flow, and aortic output were measured 15 min before ischemia and every 15 min during reperfusion. There was significantly better cardiac output in the glutamine pretreated groups. Pretreatment at 4 hours before the experiment was superior to pretreatment at 18 hours, with better maintenance of cardiac output and coronary flow. The enhanced protective effect of pretreatment at 4 hours highlights the importance of timing, and suggests a potential clinical benefit.